Moreover, RELA, TNF, IL6, TP53, MAPK1, AKT1, IL10, and ESR1 were identified as the hub targets in the HDW for RA treatment (Supplementary Table 3). This evidence concerns the gene TP53 and rheumatoid arthritis.